You can buy or sell DYN and other stocks, options, and ETFs commission-free!
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. Read More The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA. The listed name for DYN is Dyne Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low